Countless studies have shown TMS Therapy to be a safe and effective therapy with few, if any, side effects. The most common side effects include mild discomfort during treatment and slight headache following treatment. The vast majority of TMS patients leave a session and immediately return to their lives.
No anesthesia or surgery is required; patients need only sit or lie down while their heads are exposed to a magnetic field. Our outpatient TMS Therapy in Franklin is operated by our expert TMS Technicians who follow strict regulations to ensure patient safety.
If you are experiencing depression, do not hesitate to ask for the help you need. You do not have to be a current patient to do TMS with us. Feel free to reach out to one of our compassionate, experienced professionals to discuss whether TMS Therapy in Franklin is right for you. Contact us today and take the steps needed to win back your life.
Fill out our Patient Health Questionnaire as a self-assessment to assist us with your diagnosis.
Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21). NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
Important Safety Information
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
NeuroStar Advanced Therapy should not be used with patients who have non-removable conductive metal in or near the head. NeuroStar Advanced Therapy has not been studied in patients who have not received prior antidepressant treatment.